Description:

Cardiology Grand Rounds
Monday, April 21st, 2014 at 7:30am
Pritzker Auditorium (Feinberg, 3rd Floor)

Antithrombotic Therapy in Acute Coronary Syndromes:
Which Drug, When, and in Whom?

Speaker
Marc S. Sabatine, MD, MPH
Professor of Medicine
Harvard Medical School

Course Director
Clyde W. Yancy, MD, MSc
Chief, Division of Cardiology
Northwestern University Feinberg School of Medicine

(Please remember to sign in)
**No food or drink allowed in Pritzker Auditorium**
________________________________________
Disclosure Information
Dr. Sabatine is a consultant with AstraZeneca, AstraZeneca / Bristol -Myers Squibb Alliance, Bristol-Myers Squibb, Intarcia, Pfizer, Sanofi-Aventis, and Zeus. In addition, he receives grant/research support through Brigham and Women’s Hospital from Abbott Laboratories, Amgen, AstraZeneca, AstraZeneca / Bristol-Myers Squibb Alliance, Critical Diagnostics, Daiichi-Sankyo, Eisai, Genzyme, GlaxoSmithKline, Intarcia, Merck, Roche Diagnostics, Sanofi-Aventis, and Takeda. For the planning committee members of this activity, Dr. Hossein Ardehali, Dr. Donald Lloyd-Jones, Dr. Sanjiv Shah, and Michael Yensel have nothing to disclose.

FSM’s CME Leadership and Staff listed have nothing to disclose:
John X. Thomas, Jr., PhD, Sr. Associate Dean for Medical Education, Genevieve Napier, CME Director, CME Project Specialists, Jen Banys & Tara Scavelli.

Objectives
At the conclusion of this activity, participants should be able to:

1. Understand the clinical trials data regarding the efficacy and safety of different antithrombotic drugs in ACS.
2. Appreciate the utility of platelet function testing and genotyping.
3. Understand the timing of onset of action of the drugs and implications for pretreatment.

Accreditation Statement
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.